== Adverse effects ==

 
* [[Fenbufen]]: co-administration with some quinolones, including enoxacin may increase the risk of seizures. For this reason, concomitant administration of fenbufen and the quinolone should be avoided, as a precaution.<ref name="pmid3216153">{{cite journal |vauthors=Morita H, Maemura K, Sakai Y, Kaneda Y |title=[A case of convulsion, loss of consciousness and subsequent acute renal failure caused by enoxacin and fenbufen] |language=Japanese |journal=Nippon Naika Gakkai Zasshi |volume=77 |issue=5 |pages=744–5 | date=May  1988 |pmid=3216153 |doi= 10.2169/naika.77.744|url= }}<!--|accessdate=2014-09-25--></ref><ref name="pmid1446880">{{cite journal |vauthors=Hara Y, Ally A, Suzuki T, Murayama S |title=[Effects of drugs on the convulsions induced by the combination of a new quinolone antimicrobial, enoxacin, and a nonsteroidal anti-inflammatory drug, fenbufen, in mice] |language=Japanese |journal=Nippon Yakurigaku Zasshi |volume=100 |issue=4 |pages=301–5 | date=October  1992 |pmid=1446880 |doi= 10.1254/fpj.100.301|url= }}<!--|accessdate=2014-09-25--></ref><ref name="pmid9623721">{{cite journal |vauthors=Masukawa T, Nakanishi K, Natsuki R |title=Role of nitric oxide in the convulsions following the coadministration of enoxacin with fenbufen in mice |journal=Jpn. J. Pharmacol. |volume=76 |issue=4 |pages=425–9 | date=April  1998 |pmid=9623721 |doi= 10.1254/jjp.76.425|url=http://joi.jlc.jst.go.jp/JST.JSTAGE/jjp/76.425?from=PubMed |accessdate=2014-09-25}}</ref><ref name="pmid9074952">{{cite journal |vauthors=Masukawa T, Nakanishi K |title=Circadian variation in enoxacin-induced convulsions in mice coadministered with fenbufen |journal=Jpn. J. Pharmacol. |volume=73 |issue=2 |pages=175–7 | date=February  1997 |pmid=9074952 |doi= 10.1254/jjp.73.175|url=http://joi.jlc.jst.go.jp/JST.Journalarchive/jphs1951/73.175?from=PubMed |accessdate=2014-09-25}}</ref>

 
* [[Theophylline]]: in patients treated concurrently with theophylline and enoxacin, concentrations of the [[methylxanthine]] in plasma arise due to a reduced metabolic clearance of theophylline.<ref name="pmid6145999">{{cite journal |vauthors=Wijnands WJ, van Herwaarden CL, Vree TB |title=Enoxacin raises plasma theophylline concentrations |journal=Lancet |volume=2 |issue=8394 |pages=108–9 | date=July  1984 |pmid=6145999 |doi= 10.1016/s0140-6736(84)90283-6|url= }}<!--|accessdate=2014-09-25--></ref><ref name="pmid3477409">{{cite journal |vauthors=Niki Y, Soejima R, Kawane H, Sumi M, Umeki S |title=New synthetic quinolone antibacterial agents and serum concentration of theophylline |journal=Chest |volume=92 |issue=4 |pages=663–9 | date=October  1987 |pmid=3477409 |doi= 10.1378/chest.92.4.663|url=http://journal.publications.chestnet.org/article.aspx?volume=92&page=663 |accessdate=2014-09-25}}</ref><ref name="pmid8843297">{{cite journal |vauthors=Mizuki Y, Fujiwara I, Yamaguchi T, Sekine Y |title=Structure-related inhibitory effect of antimicrobial enoxacin and derivatives on theophylline metabolism by rat liver microsomes |journal=Antimicrob. Agents Chemother. |volume=40 |issue=8 |pages=1875–80 | date=August  1996 |pmid=8843297 |pmc=163433 |doi= |url=http://aac.asm.org/cgi/pmidlookup?view=long&pmid=8843297 |accessdate=2014-09-25}}</ref><ref name="pmid3191935">{{cite journal |vauthors=Sano M, Kawakatsu K, Ohkita C, Yamamoto I, Takeyama M, Yamashina H, Goto M |title=Effects of enoxacin, ofloxacin and norfloxacin on theophylline disposition in humans |journal=Eur. J. Clin. Pharmacol. |volume=35 |issue=2 |pages=161–5 |year=1988 |pmid=3191935 |doi= 10.1007/bf00609246|url= }}<!--|accessdate=2014-09-25--></ref>

 
* [[Ranitidine]], [[sucralfate]], [[antacids]] containing [[magnesium]] or [[aluminum]], supplements containing [[calcium]], [[iron]], or [[zinc]]: co-administration with these substances can lead to therapeutic failure of the antibiotic due to decreased absorbment by the intestinal tract. For example, magnesium or aluminum antacids turn enoxacin into insoluble salts that are not readily absorbed by the gastroenteric tract.<ref name="pmid2751276">{{cite journal |vauthors=Grasela TH, Schentag JJ, Sedman AJ, Wilton JH, Thomas DJ, Schultz RW, Lebsack ME, Kinkel AW |title=Inhibition of enoxacin absorption by antacids or ranitidine |journal=Antimicrob. Agents Chemother. |volume=33 |issue=5 |pages=615–7 | date=May  1989 |pmid=2751276 |pmc=172500 |doi= 10.1128/aac.33.5.615|url=http://aac.asm.org/cgi/pmidlookup?view=long&pmid=2751276 |accessdate=2014-09-25}}</ref><ref name="pmid8494374">{{cite journal |vauthors=Nix DE, Lebsack ME, Chapelsky M, Sedman AJ, Busch J, Norman A |title=Effect of oral antacids on disposition of intravenous enoxacin |journal=Antimicrob. Agents Chemother. |volume=37 |issue=4 |pages=775–7 | date=April  1993 |pmid=8494374 |pmc=187758 |doi= 10.1128/aac.37.4.775|url=http://aac.asm.org/cgi/pmidlookup?view=long&pmid=8494374 |accessdate=2014-09-25}}</ref><ref name="pmid8429114">{{cite journal |vauthors=Misiak PM, Eldon MA, Toothaker RD, Sedman AJ |title=Effects of oral cimetidine or ranitidine on the pharmacokinetics of intravenous enoxacin |journal=J Clin Pharmacol |volume=33 |issue=1 |pages=53–6 | date=January  1993 |pmid=8429114 |doi= 10.1002/j.1552-4604.1993.tb03903.x|url=http://onlinelibrary.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=0091-2700&date=1993&volume=33&issue=1&spage=53 |accessdate=2014-09-25}}</ref>
